146 related articles for article (PubMed ID: 20658231)
1. Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma.
Kim JS; Jeong YJ; Sohn MH; Lim ST; Kim DW; Jeong HJ; Kwak JY; Yim CY
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1995. PubMed ID: 20658231
[No Abstract] [Full Text] [Related]
2. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[18F]-fluoro-D-glucose (18FDG) in a patient with cutaneous T-cell lymphoma.
Mahmood S; Martínez de Llano SR
Rev Esp Med Nucl; 2007; 26(5):306. PubMed ID: 17910841
[No Abstract] [Full Text] [Related]
3. FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma.
Kuo PH; McClennan BL; Carlson K; Wilson LD; Edelson RL; Heald PW; Girardi M
Mol Imaging Biol; 2008; 10(2):74-81. PubMed ID: 18196347
[TBL] [Abstract][Full Text] [Related]
4. F-18 FDG PET/CT in granulomatous slack skin.
Hua F; Guan Y; Dai W; Zhao J; Feng X
Clin Nucl Med; 2010 Feb; 35(2):95-7. PubMed ID: 20090455
[No Abstract] [Full Text] [Related]
5. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
Kumar R; Xiu Y; Zhuang HM; Alavi A
Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
[TBL] [Abstract][Full Text] [Related]
6. Global Quantitative Techniques for Positron Emission Tomographic Assessment of Disease Activity in Cutaneous T-Cell Lymphoma and Response to Treatment.
Fardin S; Gholami S; Samimi S; Rook AH; Alavi A
JAMA Dermatol; 2016 Jan; 152(1):103-5. PubMed ID: 26422531
[No Abstract] [Full Text] [Related]
7. Primary Cutaneous Natural Killer/T-Cell Lymphoma: A Posttransplant Lymphoproliferative Disorder Demonstrated by 18F-FDG PET/CT.
Lu X; Kan Y; Wang W; Yang J
Clin Nucl Med; 2021 Jul; 46(7):595-598. PubMed ID: 33512953
[TBL] [Abstract][Full Text] [Related]
8. Folliculotropic mycosis fungoides with rare secondary pulmonary extension: potential role of FDG PET/CT in the assessment of epidermotropic T cell lymphoma.
Besson FL; Galateau-Salle F; Comoz F; Troussard X; Agostini D; Dompmartin A
Eur J Dermatol; 2013; 23(3):398-9. PubMed ID: 23774667
[No Abstract] [Full Text] [Related]
9. Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas.
Valencak J; Becherer A; Der-Petrossian M; Trautinger F; Raderer M; Hoffmann M
Haematologica; 2004 Jan; 89(1):115-6. PubMed ID: 14754619
[No Abstract] [Full Text] [Related]
10. Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings.
Schramm N; Pfluger T; Reiser MF; Berger F
Br J Radiol; 2010 May; 83(989):e90-4. PubMed ID: 20418462
[TBL] [Abstract][Full Text] [Related]
11. Aggressive variant of primary cutaneous anaplastic large T-cell lymphoma: a new role for 18F-FDG PET/CT.
Makis W; Lisbona R
Clin Nucl Med; 2010 Aug; 35(8):598-600. PubMed ID: 20631509
[No Abstract] [Full Text] [Related]
12. Colonic adenomas detected by F-FDG PET.
Felig DM; Sedarat A; Agress H; Waintraub SE
Gastrointest Endosc; 2002 Nov; 56(5):734. PubMed ID: 12397286
[No Abstract] [Full Text] [Related]
13.
Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
[TBL] [Abstract][Full Text] [Related]
14. Small Primary Cutaneous γδT-Cell Lymphoma Lesions Successfully Treated With Pralatrexate.
Imataki O; Uchida S; Yokokura S; Uemura M; Kadowaki N
Clin Nucl Med; 2019 Feb; 44(2):e85-e86. PubMed ID: 30516664
[TBL] [Abstract][Full Text] [Related]
15. Additional Findings of 18 F-AIF-FAPI-42 PET/CT in a Patient With Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma : Comparisons With 18 F-FDG PET/CT.
Liu G; Li Y; Du B; Cui Y; Li X
Clin Nucl Med; 2024 May; 49(5):e199-e201. PubMed ID: 38465934
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial.
Kuo PH; Carlson KR; Christensen I; Girardi M; Heald PW
Mol Imaging Biol; 2008; 10(6):306-14. PubMed ID: 18665425
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
[No Abstract] [Full Text] [Related]
18. Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
Liu C; Zhang Y; Zhang Y; Wang M; Liu R; Liu X; Hu S
Nucl Med Commun; 2016 May; 37(5):446-52. PubMed ID: 26657218
[TBL] [Abstract][Full Text] [Related]
19. Bilateral cutaneous diffuse large B-cell lymphoma on FDG PET/CT.
Kalender E; Yilmaz M; Erkilic S; Yilmaz M; Celen Z
Clin Nucl Med; 2011 Oct; 36(10):e153-5. PubMed ID: 21892030
[No Abstract] [Full Text] [Related]
20. The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
Qiu L; Tu G; Li J; Chen Y
Nucl Med Commun; 2017 Feb; 38(2):106-116. PubMed ID: 27792043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
